Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264251 · ClinicalTrials.gov registry record · NA
Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00264251 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 48 participants.
The verdict
NCT00264251, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are: 1. Diet + exercise program. 2. Rosiglitazone treatment. 3. A combination treatment of diet + exercise program and rosiglitazone.
Interventions
- BEHAVIORAL Weight loss through diet and exercise
- DRUG Rosiglitazone insulin sensitizing agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00264251
The ClinicalTrials.gov registry entry for NCT00264251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Weight loss through diet and exercise is the first listed.
NCT00264251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00264251 about?
NCT00264251 is a clinical study titled "Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance". The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are:...
What is the current status of trial NCT00264251?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2005-07. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00264251?
The interventions under investigation include: Weight loss through diet and exercise (BEHAVIORAL), Rosiglitazone insulin sensitizing agent (DRUG).
Who is sponsoring clinical trial NCT00264251?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.